Novartis' IFRS net income for 2022 was $6.955 billion, down 19.7% from $8.661 billion in the previous year. Revenue decreased by 2.1% to $50.545 billion from $51.626 billion a year earlier.
Novartis' IFRS net income for 2022 was $6.955 billion, down 19.7% from $8.661 billion in the previous year. Revenue decreased by 2.1% to $50.545 billion from $51.626 billion a year earlier. 
novartis.com
English (US) 